Ads
related to: mannkind news today breaking news- 3 Hottest Software Stocks
Top plays from a surging industry.
Free report names must-buy stocks.
- Top EV Stocks to Buy Now
5 EV Picks Better than Tesla
5 Stocks with Big Profit Potential
- The Top IPO Stock Plays
Could IPOs be the Key to Success?
Investing in IPOs is on the Rise
- Top Clean Energy Stocks
How to profit from surging demand.
Free report reveals 5 hot stocks.
- Free: Invest Like Buffett
5 "Buffett stocks" to buy right now
New report names 5 wealth-builders
- Top Hydrogen Stock Plays
5 Hydrogen stocks to buy right now
New report names 5 wealth-builders
- 3 Hottest Software Stocks
Search results
Results From The WOW.Com Content Network
MannKind Corp (NASDAQ: MNKD) is trading significantly lower Monday morning after the company announced the FDA issued a complete response to United Therapeutics regarding the New Drug Application ...
For premium support please call: 800-290-4726 more ways to reach us
Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL
Today's Top News Story Trump says 25% tariffs on Mexican and Canadian imports will start Tuesday, with 'no room' for delay President Donald Trump says 25% tariffs on imports from Mexico and Canada will start Tuesday, sparking renewed fears of a North American trade war More »
Let's take a look at MannKind (NAS: MNKD) today, and see why Examine its pros and cons, and decide whether its possible upside outweighs its risks. Buy, Sell, or Hold: MannKind
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991. MannKind Corporation was named after its founder, Alfred E. Mann.
MannKind (NAS: MNKD) announced breathtaking news this week -- literally. The biotech completed patient recruitment for two phase 3 clinical trials for its insulin inhalant Afrezza. The ...
Stay updated with breaking news, politics, sports, and the latest headlines on AOL.com.